DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 159 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,315 | -13.3% | 34,957 | -24.2% | 0.04% | -14.0% |
| Q2 2023 | $595,612 | -45.4% | 46,100 | -58.5% | 0.05% | -25.4% |
| Q1 2023 | $1,090,715 | +9.0% | 111,184 | +18.2% | 0.07% | +1.5% |
| Q4 2022 | $1,000,543 | +16.2% | 94,036 | +14.0% | 0.07% | +17.9% |
| Q3 2022 | $861,000 | -15.4% | 82,492 | +2.0% | 0.06% | +3.7% |
| Q2 2022 | $1,018,000 | +130.3% | 80,836 | +98.2% | 0.05% | +134.8% |
| Q1 2022 | $442,000 | -9.4% | 40,789 | +17.6% | 0.02% | -23.3% |
| Q4 2021 | $488,000 | +145.2% | 34,694 | +246.3% | 0.03% | +400.0% |
| Q1 2018 | $199,000 | – | 10,019 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |